Safety and Efficacy of Risedronate in Reducing Fracture Risk in Osteoporotic Women Aged 80 and Older: Implications for the Use of Antiresorptive Agents in the Old and Oldest Old

Objectives: To determine the efficacy of risedronate in reducing vertebral fracture risk in women aged 80 and older with osteoporosis.

[1]  S. Cummings,et al.  Design of the Fracture Intervention Trial , 2005, Osteoporosis International.

[2]  J. Bentin,et al.  Costs Induced by Hip Fractures: A Prospective Controlled Study in Belgium , 2000, Osteoporosis International.

[3]  D. Reid,et al.  Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy , 2000, Calcified Tissue International.

[4]  A. Silman,et al.  Mortality Associated with Vertebral Deformity in Men and Women: Results from the European Prospective Osteoporosis Study (EPOS) , 1998, Osteoporosis International.

[5]  R. Goodman,et al.  The effect of risedronate on the risk of hip fracture in elderly women. , 2001, The New England journal of medicine.

[6]  Dieter Felsenberg,et al.  Risedronate prevents new vertebral fractures in postmenopausal women at high risk. , 2003, The Journal of clinical endocrinology and metabolism.

[7]  O Johnell,et al.  How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. , 1998, Acta orthopaedica Scandinavica.

[8]  Hans K. Uhthoff,et al.  Current Concepts of Bone Fragility , 1986, Springer Berlin Heidelberg.

[9]  S. H. Kan,et al.  Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age. , 1988, Journal of clinical epidemiology.

[10]  H K Genant,et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.

[11]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[12]  J. Cauley,et al.  Prevalent Vertebral Deformities Predict Mortality and Hospitalization in Older Women with Low Bone Mass , 2000, Journal of the American Geriatrics Society.

[13]  P. Ross,et al.  Vertebral fracture and other predictors of physical impairment and health care utilization. , 1996, Archives of internal medicine.

[14]  François Duboeuf,et al.  Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1992 .

[15]  R. Epstein,et al.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.

[16]  H K Genant,et al.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. , 1999, Archives of internal medicine.

[17]  D. Felsenberg,et al.  Number and Type of Vertebral Deformities: Epidemiological Characteristics and Relation to Back Pain and Height Loss , 1999, Osteoporosis International.

[18]  M. Ettinger,et al.  Aging bone and osteoporosis: strategies for preventing fractures in the elderly. , 2003, Archives of internal medicine.

[19]  L. Melton,et al.  Hospitalization with Vertebral Fracture among the Aged: A National Population-Based Study, 1986–1989 , 1992, Epidemiology.

[20]  A. LaCroix,et al.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.

[21]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[22]  B. Riggs,et al.  Hip Fracture: A Disease and an Accident , 1986 .

[23]  P Geusens,et al.  Risk of new vertebral fracture in the year following a fracture. , 2001, JAMA.

[24]  M. Schlichting,et al.  Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study , 2002, Osteoporosis International.

[25]  I Larzillière,et al.  [Esophagitis associated with the use of alendronate]. , 1999, Gastroenterologie clinique et biologique.

[26]  R. Recker,et al.  Correcting calcium nutritional deficiency prevents spine fractures in elderly women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  J. Cauley,et al.  Risk of Mortality Following Clinical Fractures , 2000, Osteoporosis International.

[28]  J Pearson,et al.  Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  Harry K. Genant,et al.  Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial , 2000 .

[30]  W. Bilker,et al.  Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† , 2000, The Journal of bone and joint surgery. American volume.

[31]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[32]  H. Perry,et al.  Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. , 2000, The American journal of medicine.

[33]  S. Gehlbach,et al.  Recognition of Vertebral Fracture in a Clinical Setting , 2000, Osteoporosis International.

[34]  F Duboeuf,et al.  Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.

[35]  A. Hofman,et al.  The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  M. Hooper,et al.  Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.

[37]  J Dequeker,et al.  Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS) , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  A. Silman,et al.  The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  J W Rowe,et al.  A Prospective Study of the Effect of Fracture on Measured Physical Performance: Results from the MacArthur Study – MAC , 2000, Journal of the American Geriatrics Society.

[40]  R. Cumming,et al.  Calcium for Prevention of Osteoporotic Fractures in Postmenopausal Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  J A Kanis,et al.  Epidemiology of vertebral osteoporosis. , 1992, Bone.

[42]  D. Gold.  The clinical impact of vertebral fractures: quality of life in women with osteoporosis. , 1996, Bone.

[43]  C. Cooper,et al.  Prevalence and incidence of vertebral deformities , 1993, Osteoporosis International.

[44]  R. Wong,et al.  A new probable increasing cause of esophageal ulceration: alendronate. , 1997, The American journal of gastroenterology.

[45]  E. Duthie,et al.  The Underuse of Therapy in the Secondary Prevention of Hip Fractures , 2002, Drugs & aging.

[46]  C. Cooper,et al.  Population-based study of survival after osteoporotic fractures. , 1993, American journal of epidemiology.

[47]  David J Torgerson,et al.  Prescribing by general practitioners after an osteoporotic fracture , 1998, Annals of the rheumatic diseases.

[48]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[49]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  W. Gowin,et al.  Prevalent Vertebral Deformity Predicts Incident Hip though not distal Forearm Fracture: Results from the European Prospective Osteoporosis Study , 2001, Osteoporosis International.

[51]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[52]  A. Papaioannou,et al.  Lengthy Hospitalization Associated with Vertebral Fractures Despite Control for Comorbid Conditions , 2001, Osteoporosis International.

[53]  S. Cummings,et al.  The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study , 1998, Annals of Internal Medicine.

[54]  H. Wahner,et al.  Updated Data on Proximal Femur Bone Mineral Levels of US Adults , 1998, Osteoporosis International.